A Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Response Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.
Latest Information Update: 09 Aug 2023
At a glance
- Drugs MR-107A-02 (Primary)
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Mylan Specialty
Most Recent Events
- 01 Jul 2022 Status changed from recruiting to completed.
- 14 Apr 2022 New trial record